GRDN Guardian Pharmacy Services Inc.

  1. Stocks
  2. Healthcare
  3. NYSE: GRDN

Price (delayed)

$43.26

Market cap

$2.74B

P/E Ratio

41.2

Dividend/share

N/A

EPS

$1.05

Enterprise value

$2.69B

?
Relative Growth: Rel. Growth: 71
Relative Strength: Rel. Strength: 83
Relative Valuation: Rel. Valuation: 60
Relative Profitability: Rel. Profitability: 79
Highlights
GRDN's net income has surged by 172% year-on-year and by 24% since the previous quarter
The EPS has surged by 171% year-on-year and by 24% since the previous quarter
The debt is up by 4.6% YoY but it is down by 4.5% QoQ
The P/E is 6% above the last 4 quarters average of 40.1
Sector: Healthcare
Industry: Medical Care Facilities
Website: https://guardianpharmacy.com
Peers: CVS MCK COR CAH

Key stats

What are the main financial stats of GRDN

GRDN stock price

How has the Guardian Pharmacy Services stock price performed over time
Intraday
-3.16%
1 week
-7.01%
1 month
14.05%
1 year
68.59%
YTD
43.77%
QTD
3.32%

Financial performance

How have Guardian Pharmacy Services's revenue and profit performed over time
Revenue
$1.46B
Gross profit
$316.58M
Operating income
$86.82M
Net income
$65.91M
Gross margin
21.6%
Net margin
4.5%
GRDN's net income has surged by 172% year-on-year and by 24% since the previous quarter
The net margin has soared by 165% YoY and by 25% QoQ
GRDN's gross profit is up by 22% year-on-year and by 3.9% since the previous quarter
GRDN's gross margin is up by 10% year-on-year and by 3.3% since the previous quarter

Price vs fundamentals

How does GRDN's price correlate with its fundamentals

Growth

What is Guardian Pharmacy Services's growth rate over time

Valuation

What is Guardian Pharmacy Services stock price valuation
P/E
41.2
P/B
11.15
P/S
1.87
EV/EBIT
28.02
EV/EBITDA
22.53
EV/Sales
1.84
The EPS has surged by 171% year-on-year and by 24% since the previous quarter
The P/E is 6% above the last 4 quarters average of 40.1
GRDN's equity is up by 45% year-on-year and by 11% since the previous quarter
The P/B is 15% above the last 4 quarters average of 10.0
GRDN's price to sales (P/S) is 29% higher than its last 4 quarters average of 1.5
GRDN's revenue is up by 10% year-on-year

Efficiency

How efficient is Guardian Pharmacy Services business performance
GRDN's ROA has soared by 159% YoY and by 18% from the previous quarter
GRDN's ROE has soared by 150% year-on-year and by 13% since the previous quarter
The return on sales has increased by 20% since the previous quarter
The ROIC is up by 20% from the previous quarter

Dividends

What is GRDN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GRDN.

Financial health

How did Guardian Pharmacy Services financials performed over time
GRDN's total assets is 139% greater than its total liabilities
GRDN's quick ratio has surged by 62% year-on-year and by 15% since the previous quarter
GRDN's current ratio is up by 40% year-on-year and by 13% since the previous quarter
The debt is 86% lower than the equity
GRDN's equity is up by 45% year-on-year and by 11% since the previous quarter
The debt to equity has declined by 30% year-on-year and by 18% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.